Your browser doesn't support javascript.
loading
Neoadjuvant Nivolumab for Patients With Resectable Merkel Cell Carcinoma in the CheckMate 358 Trial.
Topalian, Suzanne L; Bhatia, Shailender; Amin, Asim; Kudchadkar, Ragini R; Sharfman, William H; Lebbé, Celeste; Delord, Jean-Pierre; Dunn, Lara A; Shinohara, Michi M; Kulikauskas, Rima; Chung, Christine H; Martens, Uwe M; Ferris, Robert L; Stein, Julie E; Engle, Elizabeth L; Devriese, Lot A; Lao, Christopher D; Gu, Junchen; Li, Bin; Chen, Tian; Barrows, Adam; Horvath, Andrea; Taube, Janis M; Nghiem, Paul.
Affiliation
  • Topalian SL; Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Bhatia S; University of Washington, Seattle Cancer Care Alliance, Seattle, WA.
  • Amin A; Levine Cancer Institute, Atrium Healthcare, Charlotte, NC.
  • Kudchadkar RR; Winship Cancer Institute of Emory University, Atlanta, GA.
  • Sharfman WH; Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Lebbé C; Université de Paris, INSERM U976, and Dermatology and CIC, AP-HP, Saint Louis Hospital, Paris, France.
  • Delord JP; Institut Claudius Regaud, IUCT-Oncopole, Toulouse, France.
  • Dunn LA; Memorial Sloan Kettering Cancer Center, New York, NY.
  • Shinohara MM; University of Washington, Seattle Cancer Care Alliance, Seattle, WA.
  • Kulikauskas R; University of Washington, Seattle Cancer Care Alliance, Seattle, WA.
  • Chung CH; H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL.
  • Martens UM; SLK-Clinics, MOLIT Institute, Heilbronn, Germany.
  • Ferris RL; University of Pittsburgh Medical Center Hillman Cancer Center, Pittsburgh, PA.
  • Stein JE; Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Engle EL; Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Devriese LA; University Medical Center Utrecht, Cancer Center, Utrecht, the Netherlands.
  • Lao CD; University of Michigan Comprehensive Cancer Center, Ann Arbor, MI.
  • Gu J; Bristol Myers Squibb, Princeton, NJ.
  • Li B; Bristol Myers Squibb, Princeton, NJ.
  • Chen T; Bristol Myers Squibb, Princeton, NJ.
  • Barrows A; Bristol Myers Squibb, Princeton, NJ.
  • Horvath A; Bristol Myers Squibb, Princeton, NJ.
  • Taube JM; Johns Hopkins Bloomberg∼Kimmel Institute for Cancer Immunotherapy, Sidney Kimmel Comprehensive Cancer Center, Baltimore, MD.
  • Nghiem P; University of Washington, Seattle Cancer Care Alliance, Seattle, WA.
J Clin Oncol ; 38(22): 2476-2487, 2020 08 01.
Article in En | MEDLINE | ID: mdl-32324435
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Merkel Cell / Neoadjuvant Therapy / Antineoplastic Agents, Immunological / Nivolumab / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Document type: Article Affiliation country: Country of publication:
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Skin Neoplasms / Carcinoma, Merkel Cell / Neoadjuvant Therapy / Antineoplastic Agents, Immunological / Nivolumab / Neoplasm Recurrence, Local Type of study: Clinical_trials / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Aged / Aged80 / Female / Humans / Male / Middle aged Language: En Journal: J Clin Oncol Year: 2020 Document type: Article Affiliation country: Country of publication: